Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease-Reference-Cited by-同舟云学术

Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease

Published:2019-12 Issue:24 Volume:12 Page:2515-2524
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Ouriel Kenneth,Adelman Mark A.,Rosenfield Kenneth,Scheinert Dierk,Brodmann Marianne,Peña Constantino,Geraghty Patrick,Lee Arthur,White Roseann,Clair Daniel G.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis;Fowkes;Lancet,2013

2. Lower extremity peripheral artery disease and quality of life among older individuals in the community;Wu;J Am Heart Assoc,2017

3. An update on methods for revascularization and expansion of the TASC Lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II);Jaff;Vasc Med,2015

4. Drug-eluting stent implantation and long-term survival following peripheral artery revascularization;Secemsky;J Am Coll Cardiol,2019

5. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg;Tepe;N Engl J Med,2008

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases;European Heart Journal;2024-08-30

2. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions at long-term follow-up: A network meta-analysis of randomized controlled trials;International Journal of Cardiology;2024-06

3. Device regulation and surveillance in vascular care: Challenges and opportunities;Catheterization and Cardiovascular Interventions;2024-04-19

4. A New Drug-Coated Balloon for the Treatment of Superficial Femoropopliteal Artery Disease: 12-Month Results from the IN-DEPT SFA Trial;Journal of Vascular and Interventional Radiology;2024-02

5. Five-Year Safety and Effectiveness of Paclitaxel Drug-Coated Balloons Alone or With Provisional Bare Metal Stenting for Real-World Femoropopliteal Lesions: IN.PACT Global Study Subgroup Analysis;Circulation: Cardiovascular Interventions;2024-02